Literature DB >> 7983708

The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane.

A R Stewart1, A E Tollefson, P Krajcsi, S P Yei, W S Wold.   

Abstract

The adenovirus type 2 and 5 E3 10,400- and 14,500-molecular-weight (10.4K and 14.5K) proteins are both required to protect some cell lines from lysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor. We have shown previously that both 10.4K and 14.5K are integral membrane proteins and that 14.5K is phosphorylated and O glycosylated. The 10.4K protein coimmunoprecipitates with 14.5K, indicating that the two proteins function as a complex. Here we show, using immunofluorescence and two different cell surface-labeling techniques, that both proteins are localized in the plasma membrane. In addition, we show that trafficking of each protein to the plasma membrane depends on concomitant expression of the other protein. Finally, neither protein could be immunoprecipitated from conditioned media, indicating that neither is secreted. Taken together, these results suggest that the plasma membrane is the site at which 10.4K and 14.5K function to inhibit cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7983708      PMCID: PMC188561          DOI: 10.1128/JVI.69.1.172-181.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

Review 2.  The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling.

Authors:  R Kolesnick; D W Golde
Journal:  Cell       Date:  1994-05-06       Impact factor: 41.582

3.  Nucleotide sequence of the EcoRI E fragment of adenovirus 2 genome.

Authors:  J Hérissé; F Galibert
Journal:  Nucleic Acids Res       Date:  1981-03-11       Impact factor: 16.971

4.  Nucleotide sequence of the EcoRI D fragment of adenovirus 2 genome.

Authors:  J Hérissé; G Courtois; F Galibert
Journal:  Nucleic Acids Res       Date:  1980-05-24       Impact factor: 16.971

5.  Human adenoviruses: growth, purification, and transfection assay.

Authors:  M Green; W S Wold
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

6.  A new animal model for human respiratory tract disease due to adenovirus.

Authors:  D L Pacini; E J Dubovi; W A Clyde
Journal:  J Infect Dis       Date:  1984-07       Impact factor: 5.226

7.  Human adenovirus 2 E1B-19K and E1B-53K tumor antigens: antipeptide antibodies targeted to the NH2 and COOH termini.

Authors:  M Green; K H Brackmann; L A Lucher; J S Symington; T A Kramer
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

8.  Use of nondefective adenovirus-simian virus 40 hybrids for mapping the simian virus 40 genome.

Authors:  T J Kelly; A M Lewis
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

9.  Purification and characterization of an early protein (E14K) from adenovirus type 2-infected cells.

Authors:  H Persson; B Oberg; L Philipson
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

10.  Mapping a new gene that encodes an 11,600-molecular-weight protein in the E3 transcription unit of adenovirus 2.

Authors:  W S Wold; C Cladaras; S C Magie; N Yacoub
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

View more
  24 in total

1.  Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.

Authors:  K B Elkon; C C Liu; J G Gall; J Trevejo; M W Marino; K A Abrahamsen; X Song; J L Zhou; L J Old; R G Crystal; E Falck-Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Open reading frame E3-10.9K of subspecies B1 human adenoviruses encodes a family of late orthologous proteins that vary in their predicted structural features and subcellular localization.

Authors:  Kathryn M Frietze; Samuel K Campos; Adriana E Kajon
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

3.  Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2.

Authors:  Drew L Lichtenstein; Konstantin Doronin; Karoly Toth; Mohan Kuppuswamy; William S M Wold; Ann E Tollefson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Genetic organization, size, and complete sequence of early region 3 genes of human adenovirus type 41.

Authors:  H Y Yeh; N Pieniazek; D Pieniazek; R B Luftig
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis.

Authors:  J Shisler; C Yang; B Walter; C F Ware; L R Gooding
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination.

Authors:  A P Byrnes; R E MacLaren; H M Charlton
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

7.  Adenovirus RIDalphabeta complex inhibits lipopolysaccharide signaling without altering TLR4 cell surface expression.

Authors:  Fernando Delgado-Lopez; Marshall S Horwitz
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

8.  Distinct domains in the adenovirus E3 RIDalpha protein are required for degradation of Fas and the epidermal growth factor receptor.

Authors:  Tom A Zanardi; Soonpin Yei; Drew L Lichtenstein; Ann E Tollefson; William S M Wold
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  The adenovirus E3 RID complex protects some cultured human T and B lymphocytes from Fas-induced apoptosis.

Authors:  Adrienne L McNees; C T Garnett; Linda R Gooding
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model.

Authors:  T E Sparer; R A Tripp; D L Dillehay; T W Hermiston; W S Wold; L R Gooding
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.